References
- Nayerossadat N, Maedeh T, Ali P. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 2012; 1: 27. doi:10.4103/2277-9175.98152
- Lan T, Que H, Luo M, Zhao X, Wei X. Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy. Mol Cancer 2022; 21: 1-15. doi: 10.1186/s12943-022-01550-8
- Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 29. doi: 10.1186/1475-925X-13-29
- Čemažar M, Miklavčič D, Serša G. Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res 1998; 89: 328-33. doi: 10.1111/j.1349-7006.1998.tb00566.x
- Serša G, Novaković S, Miklavčič D. Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett 1993; 69: 81-4. doi: 10.1016/0304-3835(93)90159-7
- Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 1972; 10: 279-90. doi: 10.1007/BF01867861
- Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-57. doi: 10.1002/(sici)1097-0142(19980701)83:1<;148::aid-cncr20>3.0.co;2-w
- Vivod G, Jesenko T, Gasljevic G, Kovacevic N, Bosnjak M, Sersa G, et al. Treatment of vulvar cancer recurrences with electrochemotherapy - a detailed analysis of possible causes for unsuccessful treatment. Radiol Oncol 2023; 57: 121-6. doi: 10.2478/raon-2023-0010
- Campana LG, Tauceri F, Bártolo J, Calabrese S, Odili J, Carrara G, et al. Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study. Eur J Surg Oncol 2024; 5: 108740. doi: 10.1016/j.ejso.2024.108740
- Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/j. ejso.2018.01.090
- Cemazar M, Jarm T, Sersa G. Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010; 10: 300-11. doi: 10.2174/156652310791823425
- Dolinsek T, Sersa G, Prosen L, Bosnjak M, Stimac M, Razborsek U, et al. Electrotransfer of plasmid DNA encoding an anti-mouse endoglin (CD105) shRNA to B16 melanoma tumors with low and high metastatic potential results in pronounced anti-tumor effects. Cancers 2015; 8: 3. doi: 10.3390/cancers8010003
- Bosnjak M, Dolinsek T, Cemazar M, Kranjc S, Blagus T, Markelc B, et al. Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma. Gene Ther 2015; 22: 578-90. doi: 10.1038/gt.2015.26
- Kamensek U, Cemazar M, Lampreht Tratar U, Ursic K, Sersa G. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model. Cancer Immunol Immunother 2018; 67: 785-95. doi: 10.1007/s00262-018-2133-0
- Rosazza C, Buntz A, Rieß T, Wöll D, Zumbusch A, Rols M-P. Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther 2013; 21: 2217-26. doi: 10.1038/mt.2013.182
- Komel T, Bosnjak M, Sersa G, Cemazar M. Expression of GFP and DsRed fluorescent proteins after gene electrotransfer of tumour cells in vitro. Bioelectrochemistry 2023; 153: 108490. doi: 10.1016/j.bioelech-em.2023.108490
- Markelc B, Tevz G, Cemazar M, Kranjc S, Lavrencak J, Zegura B, et al. Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Therapy 2012; 19: 312-20. doi: 10.1038/gt.2011.97
- Tevz G, Pavlin D, Kamensek U, Kranjc S, Mesojednik S, Coer A, et al. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression. Technol Cancer Res Treat 2008; 7: 91-101. doi: 10.1038/gt.2011.97
- André FM, Gehl J, Sersa G, Préat V, Hojman P, Eriksen J, et al. Efficiency of high-and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008; 19: 1261-72. doi: 10.1089/hum.2008.060
- Ursic K, Kos S, Kamensek U, Cemazar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release 2021; 332: 623-35. doi: 10.1016/j.jconrel.2021.03.009
- Sedlar A, Dolinsek T, Markelc B, Prosen L, Kranjc S, Bosnjak M, et al. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 2012; 46: 302-11. doi: 10.2478/v10019-012-0044-9
- Smith AJ, Clutton RE, Lilley E, Hansen KEA, Brattelid T. PREPARE: guidelines for planning animal research and testing. Lab Anim 2018; 52: 135-141. doi: 10.1177/0023677217724823
- De Vleeschauwer SI, van de Ven M, Oudin A, Debusschere K, Connor K, Byrne AT, et al. OBSERVE: guidelines for the refinement of rodent cancer models. Nat Protoc 2024; 19: 2571-2596. doi: 10.1038/s41596-024-00998-w
- Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 2020; 18: e3000410. doi: 10.1371/journal.pbio.3000410
- Cemazar M, Golzio M, Sersa G, Escoffre JM, Coer A, Vidic S, et al. Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors. Hum Gene Ther 2011; 23: 128. doi: 10.1089/hum.2011.073
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Supp 2006; 4: 3-13. doi: 10.1016/j.ejcsup.2006.08.002
- Cvetkoska A, Maček-Lebar A, Trdina P, Miklavčič D, Reberšek M. Muscle contractions and pain sensation accompanying high-frequency electroporation pulses. Sci Rep 2022; 12: 1-15. doi: 10.1038/s41598-022-12112-9
- Scuderi M, Dermol-Cerne J, Scancar J, Markovic S, Rems L, Miklavcic D, et al. The equivalence of different types of electric pulses for electrochemotherapy with cisplatin – an in vitro study. Radiol Oncol 2024; 58: 51-66. doi: 10.2478/raon-2024-0005
- Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, Hwang GL, et al. Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol 2018; 29: 893-8.e4. doi: 10.5306/wjco.v12.i5.367
- Znidar K, Bosnjak M, Cemazar M, Heller LCLC. Cytosolic DNA sensor upregulation accompanies DNA electrotransfer in B16.F10 melanoma cells. Mol Ther Nucl Acids 2016; 5: e322. doi: 10.1038/mtna.2016.34
- Znidar K, Bosnjak M, Heller LC, Čemažar M. Electrostransfer of plasmid gWIZ blank into B16-F10 and TS/A increase expression of cytosolic DNA PRRs. In: IFMBE Proceedings. 2016; 53: 183. doi: 10.1007/978-981-287-817-5_41
- Semenova N, Bosnjak M, Markelc B, Znidar K, Cemazar M, Heller L. Multiple cytosolic DNA sensors bind plasmid DNA after transfection. Nucleic Acids Res 2019; 47: 10235-46. doi: 10.1093/nar/gkz768
- Bosnjak M, Jesenko T, Kamensek U, Sersa G, Lavrencak J, Heller L, et al. Electrotransfer of different control plasmids elicits different antitumor effectiveness in B16.F10 melanoma. Cancers 2018; 10: 37. doi: 10.3390/cancers10020037
- Bosnjak M, Lorente BC, Pogacar Z, Makovsek V, Cemazar M. Different incubation times of cells after gene electrotransfer in fetal bovine serum affect cell viability, but not transfection efficiency. J Memb Biol 2014; 247: 421-8. doi: 10.1007/s00232-014-9649-9
- Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315-27. doi: 10.1007/s00262-015-1724-2
- Kos S, Bosnjak M, Jesenko T, Markelc B, Kamensek U, Znidar K, et al. Non-clinical in vitro evaluation of antibiotic resistance gene-free plasmids encoding human or murine IL-12 intended for first-in-human clinical study. Pharmaceutics 2021; 13: 1739. doi: 10.3390/pharmaceutics13101739
- Markelc B, Jesenko T, Kranjc Brezar S, Omerzel M, Lampreht Tratar U, Rencelj A, et al. Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study. Sci Rep 2024; 14: 22288. doi: 10.1038/s41598-024-73314-x
- Strojan P, Jesenko T, Omerzel M, Jamsek C, Groselj A, Tratar UL, et al. Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region. Eur J Surg Oncol 2025; 51:109574. doi: 10.1016/j.ejso.2025.109574
- Lampreht Tratar U, Jesenko T, Omerzel M, Seliskar A, Stupan U, Djokic M, et al. Safety and efficacy of IL-12 plasmid DNA transfection into pig skin: supportive data for human clinical trials on gene therapy and vaccination. Int J Mol Sci 2024; 25: 3151. doi: 10.3390/IJMS25063151
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020
- Conniff AS, Tur J, Kohena K, Zhang M, Gibbons J, Heller LC. DNA electrotransfer regulates molecular functions in skeletal muscle. Bioelectricity 2024; 6: 80-90. doi: 10.1089/bioe.2022.0041
- Spanggaard I, Dahlstroem K, Laessoee L, Hansen RH, Johannesen HH, Hendel HW, et al. Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP. Acta Oncol 2017; 56: 909-16. doi: 10.1080/0284186X.2017.1315171
- Aurisicchio L, Brambilla N, Cazzaniga ME, Bonfanti P, Milleri S, Ascierto PA, et al. A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19. Mol Ther 2022; 31: 788. doi: 10.1016/j.ymthe.2022.12.017
- Lampreht Tratar U, Milevoj N, Cemazar M, Znidar K, Ursic Valentinuzzi K, Brozic A, et al. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12. Int Immunopharmacol 2023; 120: 110274. doi: 10.1016/j.intimp.2023.110274
- Clover AJP, Bertino G, Curatolo P, Odili J, Campana L, Kunte C, et al. Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan-European InspECT Database for 1478 lesions in 691 patients (2008-2018). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejso.2018.10.090.